High activity of rituximab combined with cladribine and cyclophosphamide in a patient with pulmonary lymphomatoid granulomatosis and bone marrow involvement.

Authors	Tadeusz Robak, Radzisław Kordek, Halina Urbanska-Rys, Pawel Robak, Jacek Bartkowiak, Andrzej Bednarek, Cezary Chudobinski, Krzysztof Chojnowski
Journal	Leukemia & lymphoma (Leuk Lymphoma) Vol. 47 Issue 8 Pg. 1667-9 (Aug 2006) ISSN: 1042-8194 [Print] United States
PMID	16966281 (Publication Type: Case Reports, Letter)
Chemical References	Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Cladribine Rituximab Cyclophosphamide
Topics	Antibodies, Monoclonal (therapeutic use) Antibodies, Monoclonal, Murine-Derived Antineoplastic Combined Chemotherapy Protocols (therapeutic use) Bone Marrow Diseases Cladribine (therapeutic use) Cyclophosphamide (therapeutic use) Female Humans Lung Diseases Lymphomatoid Granulomatosis (drug therapy, pathology) Middle Aged Rituximab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!